Keywords: AstraZeneca, Astellas, Symbicort, Japan approval, US Medicaid, Law suit

Japanese approval for AstraZeneca/Astellas’ Symbicort; AZ fined $115 million in USA

Article | 16 October 2009

Anglo-Swedish drug major AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol) has been approved by Japan’s Ministry of Health, Labor and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Astra Zeneca

AstraZeneca

Amgen

GlaxoSmithKline

Bristol-Myers Squibb

Go to company listing

Related Drugs

Budesonide and Formoterol Fumarate Dihydrate

Symbicort

Budesonide

Entocort EC

Pulmicort Turbuhaler

Go to drug listing